Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2024 Mar 1.
Published in final edited form as: Prev Med. 2023 Jan 11;168:107422. doi: 10.1016/j.ypmed.2023.107422

Sex differences in Cannabis Use Disorder and associated psychosocial problems among US adults, 2012-2013

Sarah Gutkind 1, Dvora Shmulewitz 2,3, Deborah Hasin 1,2,3
PMCID: PMC9974921  NIHMSID: NIHMS1868207  PMID: 36641126

Abstract

While men show greater prevalence of cannabis use disorder (CUD) than women, whether cannabis use frequency drives this difference is unknown, and little is known about sex differences in problems associated with CUD. We therefore assessed the association of CUD with sex, adjusted for frequency of use, and compared the association of psychosocial and health-related problems with CUD between men and women. We included US adults age ≥18 who reported past-year cannabis use in the 2012-2013 National Epidemiologic Survey on Alcohol and Related Conditions-III (n=3,701). Cannabis use frequency, DSM-5 CUD and problems (interpersonal, financial, legal, health-related) were assessed. Associations between psychosocial problems, sex and DSM-5 CUD were assessed using prevalence differences (PD) and 95% confidence intervals (CI) from logistic regression models, controlling for demographics and cannabis use frequency, and effect modification by sex was assessed. We found that the prevalence of CUD among men versus women was not significantly greater after adjusting for use frequency. Women had significantly higher prevalence of interpersonal, financial and health-related problems than men, adjusting for frequency of use. Women showed significantly greater association of CUD with interpersonal problems with a boss or co-workers (p<0.05) and a neighbor, relative or friend (p<0.05) compared to men. Lack of sex differences in CUD after adjusting for frequency of use suggests use frequency may be an important target of CUD prevention efforts. CUD showed stronger associations for interpersonal problems among women than men, suggesting the need for particular emphasis on treating interpersonal problems related to cannabis use among women.

Keywords: Cannabis Use Disorder, Health Problems, Psychosocial Problems, NESARC-III, Sex Differences

INTRODUCTION

Cannabis use disorder (CUD) is prevalent among people who use cannabis and may be associated with adverse medical and social consequences. A recent meta-analysis indicated that approximately 20% of cannabis users and 33% of frequent users developed CUD.1 Adult cannabis use and CUD have increased in the past two decades, with over 4.2 million US adults meeting CUD criteria in 2019.26 Increasing rates of CUD are cause for concern because CUD is associated with mental illnesses,7,8 e.g., substance-induced psychosis and schizophrenia,912 cannabis-related healthcare utilization,13 emergency department utilization,14 severe functional impairment,15 and psychosocial problems.14 Thus, gaining a better understanding of the subgroups at particular risk for CUD-related psychosocial and health problems is an important public health priority.

Prior studies indicate potential sex differences in the epidemiology of cannabis use, CUD and CUD-related problems. Although there is mixed evidence regarding sex differences in cannabis use trends over time,3,1618 rates of CUD are consistently higher among adult men,7,8,15,17,19 and men have an increased probability of transitioning from use to CUD.20,21 In contrast, women have been shown to transition to CUD more quickly after cannabis initiation.7,8,18 Transition differences may be due to increased cannabis use frequency and may contribute to sex differences in CUD-related problems. For example, one study suggested that only in women, CUD is associated with lower ability to meet physical roles, worse bodily pain and worse general health.22 This study also revealed a dose-dependent relationship between cannabis use frequency and quality of life, and sex differences in this relationship, as among women each joint smoked was associated with greater reductions in mental health scores than men.22 Another study7 found that among those with CUD, women were more likely to be unemployed, widowed/divorced, and have mood and anxiety disorders. These studies highlight important differences in characteristics of men and women with CUD and potential differences in CUD-associated problems, but neither study adjusted for cannabis use frequency. As frequent cannabis use is associated with a greater likelihood of developing CUD1 and experiencing CUD-related problems,23 further research evaluating sex differences in CUD-associated problems adjusting for cannabis use frequency is necessary.

Our previous work found that CUD was associated with psychosocial and health-related problems, but did not examine sex differences in CUD-associated problems.14 Given national increases in the prevalence of CUD, determining sex differences in such problems is important to inform prevention and intervention strategies. This study leveraged nationally representative data on US adults who reported past-year cannabis use from the 2012-2013 National Epidemiologic Survey on Alcohol and Related Conditions-III (NESARC-III) to investigate sex differences in: 1) the frequency of cannabis use; 2) CUD prevalence adjusting for cannabis use frequency; 3) the burden of psychosocial and health problems adjusting for cannabis use frequency and CUD; and 4) the burden of psychosocial and health-related problems associated with CUD. This study builds on previous work in this nationally representative sample14 by restricting our sample to past-year cannabis users at risk for CUD, adjusting for cannabis use frequency, and exploring important sex differences in psychosocial and health-related problems.

METHODS

Study Design and Study Population

We used data from the 2012-2013 NESARC-III, a nationally representative cross-sectional household survey of US adults (ages 18±).24 Non-institutionalized adults (N=36,309) were selected using a multi-stage probability sampling approach, and Hispanic, Black, and Asian respondents were oversampled.25 Household, person-level, and overall response rates were 72.0%, 84.0% and 60.1%, respectively.24 Sample weights adjusted for oversampling and non-response.24,25 Data were collected 04/2012-06/2013 by trained interviewers who conducted face-to-face interviews using computer-assisted personal interviews.25 Participants provided informed consent and received financial compensation for participation.25 NESARC-III protocols and consent procedures were approved by Institutional Review Boards at the National Institutes of Health and Westat. The analytic sample was limited to participants who reported any past-year cannabis use (n=3,701), since cannabis use is a necessary condition for developing CUD.

Frequency of Past-year Cannabis Use

Frequency of use was assessed by asking “how often did you use cannabis in the past 12 months.” Responses included using everyday, 5-6 times/week, 3–4 times/week, 1–2 times/week, 2–3 times/month, once a month, 7–11 times/year, 3–6 times/year, 2 times/year, and once in the last year. Frequency of use was considered an outcome in analysis of sex differences, and a predictor in associations of CUD and problems with sex. In the model with frequency of use as an outcome, responses were converted to number of days used in the past year for easier interpretation. We estimated the number of days used by multiplying: number of times per day by 365; per week by 52; per month by 12; and per year by 1. For categories with ranges of responses, the average of the endpoints was rounded to the nearest integer (e.g., 5-6 times a week was ((5*52)+(6*52))/2=286 days, and 2-3 times a month was ((2*12)+(3*12))/2=30 days).

Past-Year CUD

CUD was assessed using the Alcohol Use Disorder and Associated Disabilities Interview Schedule 5th Edition (AUDADIS-5), a structured diagnostic interview using the Diagnostic and Statistical Manual of Mental Disorders 5th edition (DSM-5) criteria to assess substance use disorders and other psychiatric disorders. Respondents were positive if they met 2± of the eleven DSM-5 CUD criteria in the past 12 months. Past-year DSM-5 CUD showed moderate test-retest reliability in the general population (kappa=0.41); with 2.86 weeks between test and re-test on average (range:1-10 weeks).26 The procedural validity of the AUDADIS-5 was appraised using clinician-administered, semi-structured interviews with the Psychiatric Research Interview for Substance and Mental DSM-5 (PRISM-5) in a general population, and showed moderate concordance for past-year CUD (kappa=0.60).27 The PRISM-5 is a good comparator because the test-retest reliability of DSM-5 CUD in the PRISM-5 indicated substantial reliability in a general population (kappa=0.74), with 5.27 days between test and re-test on average (range:1-21 days).28 Past-year CUD was considered an outcome in analysis of sex differences and a predictor of psychosocial and health problems.

Outcomes: Past-year Psychosocial and Health-related Problems

Past-year psychosocial problems (i.e., interpersonal, financial, legal) and health-related problems were assessed in separate modules from substance use questions.14 Respondents were asked if they had a series of experiences in the past year (yes/no). Interpersonal problems included: having trouble with a boss or co-worker; having problems with a neighbor, relative or friend; or breaking off a major relationship. Financial problems included: being fired or laid off from a job, being unemployed and looking for a job for more than a month, declaring bankruptcy, experiencing so much debt they could not repay it, or being homeless. Legal problems included having serious trouble with the police/law. Health-related problems included hospitalization, emergency department care, serious injury, sleep problems, and suicide attempt. Hospitalization was positive if respondents reported at least one overnight stay in a hospital, not due to childbirth. Emergency treatment was positive if respondents reported medical care in an emergency department at least once. Serious injury was positive if respondents reported at least one injury that caused them to seek medical help or cut down usual activities for more than half a day. Experiencing sleep problems was positive if respondents reported problems falling or staying asleep. Finally, respondents were categorized as experiencing a current suicide attempt if the age of their first or most recent suicidal attempt was their current age.

Covariates

Sociodemographic covariates included age, sex (male, female), education (less than high school education, high school, or more than high school), and race/ethnicity (non-Hispanic white, non-Hispanic Black, Hispanic, Other [non-Hispanic American Indian/ Alaska Native/ Asian/ Native Hawaiian/ Pacific Islander/ Mixed race]). Substance use covariates included past-year alcohol use, past-year illicit drug use (i.e., cocaine, club drugs, hallucinogens, inhalants, heroin and other drugs, and non-medical use of prescription sedatives, opioids, and stimulants), past-year DSM-5 alcohol use disorder (AUD), and past-year DSM-5 drug use disorder (DUD) (i.e., disorder involving any of the drugs listed above). Sex was included as a potential moderator of the relationship between CUD and psychosocial and health-related problems.

Statistical Analysis

We applied sample weights and described sample characteristics using weighted prevalences. We used a Poisson regression model to determine the association between sex and past-year cannabis use frequency (days). We used a series of logistic regression models to determine the association between sex (men vs. women) and past-year CUD, the association between psychosocial and health-related problems and sex and CUD, and whether the associations between these problems and CUD differed by sex. We back-transformed model estimates to the prevalence scale, and association was reported as the prevalence difference (PD), for ease of interpretation and to limit unobserved heterogeneity bias with odds ratios.29 All tests were 2-tailed, with significance set at p<.05, as indicated by 95% confidence intervals not including 0.0. Analyses were conducted using SUDAAN 11.0.1 to adjust for complex sampling by incorporating sampling weights.

We first compared the average frequency of past-year cannabis use between men and women, adjusting for age, race/ethnicity, and education. We then compared past-year CUD between men and women, adjusting for age, race/ethnicity, and education, and past-year cannabis use frequency. The reported PDs represent the prevalence of CUD among men minus the prevalence of CUD among women. Next we examined the association between each psychosocial/ health-related problem and sex, adjusted for age, race/ethnicity, and education level, cannabis use frequency and CUD. The reported PD represents the prevalence of the problem among women minus the prevalence of the problem among men. Similarly, we assessed association of each psychosocial/ health-related problem with CUD, with the PD representing prevalence of the problem among those with CUD minus among those without CUD. To determine if these associations differed by sex, we incorporated an interaction term (CUD*sex) in regression models, and associations (PDs) were contrasted for women versus men. In sensitivity analyses we repeated our analyses with two additional models additionally adjusting for: (1) past-year alcohol and drug use, and (2) past-year AUD and DUD. Previous literature indicates that co-occurring AUD and CUD, or CUD and other DUDs may contribute to greater problems than either disorder alone,14,30,31 making it important to additionally adjust for past-year AUD and DUDs that may compound the problems associated with CUD.

RESULTS

Sample Description

This sample of adults with any past-year cannabis use (n=3,701) was predominantly male (62%), ages 18-29 (48%), non-Hispanic white (65%), and had more than a high school education (58%) (Table 1). Approximately one quarter had past-year DSM-5 CUD (n=972, 27%), 47% had past-year DSM-5 AUD, and 9.7% had past-year DSM-5 DUD. Participants with CUD were younger (58% ages 18-29), more likely to be non-Hispanic Black (21%), have AUD (59%) or DUD (15%), and less likely to have more than a high school education (53%) compared with the overall sample and participants without CUD. Approximately one third of the sample reported cannabis use every day or nearly every day in the past year (29%). This differed by CUD status: 54% of people with CUD reported cannabis use every day or nearly every day in the past year, compared with 20% of people without CUD. The majority of participants without CUD used cannabis less than once per week (62%). Prevalence of the psychosocial problems in the overall sample, and among people with and without CUD are reported in Supplemental Table 1.

Table 1:

Sample Description, overall and by DSM-5 cannabis use disorder (CUD), among NESARC-III past year cannabis users (N=3,701)

CUD
Whole sample
(N=3,701)
Yes
(n=972; 26.7% [SE=0.95])
No
(n=2,729; 73.3% [SE=0.95])

n % (SE) n % (SE) n % (SE)
Sociodemographic characteristics

Sex
   Men 2181 62.24 (1.19) 620 66.10 (2.07) 1561 60.83 (1.26)
   Women 1520 37.76 (1.19) 352 33.90 (2.07) 1168 39.17 (1.26)

Age
   18-29 1638 48.31 (1.22) 525 58.43 (2.06) 1113 44.62 (1.47)
   30-44 1100 27.38 (0.89) 281 25.60 (1.85) 819 28.03 (1.13)
   45-64 879 21.88 (0.87) 154 14.45 (1.39) 725 24.59 (1.16)
   65+ 84 2.43 (0.41) 12 1.51 (0.57) 72 2.76 (0.46)

Race/Ethnicity
   Non-Hispanic White 1922 65.40 (1.31) 442 58.21 (1.92) 1480 68.02 (1.46)
   Non-Hispanic Black 976 15.74 (1.06) 315 20.77 (1.86) 661 13.90 (1.06)
   Hispanic 612 13.06 (0.80) 167 14.93 (1.20) 445 12.39 (0.89)
   Other 191 5.80 (0.63) 48 6.09 (1.08) 143 5.69 (0.64)

Education level
   Less than high school 557 13.29 (0.68) 172 16.15 (1.31) 385 12.24 (0.83)
   High school 1030 28.22 (0.93) 291 30.70 (1.63) 739 27.32 (1.09)
   More than high school 2114 58.49 (1.09) 509 53.15 (1.89) 1605 60.44 (1.33)

Frequency past year cannabis use (number of days a )

Every day (365) 732 17.44 (0.85) 336 32.63 (2.01) 396 11.91 (0.77)
Nearly every day: 5-6 times a week (286) 429 11.89 (0.73) 195 21.26 (1.98) 234 8.48 (0.64)
3-4 times a week (182) 366 9.29 (0.62) 146 15.00 (1.27) 220 7.21 (0.64)
1-2 times a week (78) 377 10.15 (0.61) 94 10.14 (1.03) 283 10.16 (0.71)
2-3 times a month (30) 372 10.01 (0.57) 69 7.37 (1.06) 303 10.97 (0.69)
Once a month (12) 303 8.30 (0.54) 43 4.56 (0.84) 260 9.66 (0.74)
7-11 times in last year (9) 210 5.91 (0.52) 38 3.49 (0.69) 172 6.79 (0.65)
3-6 times in last year (5) 362 10.79 (0.72) 25 3.03 (0.67) 337 13.62 (0.97)
2 times in last year (2) 307 8.90 (0.51) 14 1.18 (0.37) 293 11.71 (0.66)
Once in last year (1) 231 6.97 (0.51) 8 0.70 (0.29) 223 9.25 (0.69)
Missing 12 0.35 (0.12) 4 0.65 (0.36) 8 0.24 (0.10)

Other substance use/disorder

Past year alcohol use 3460 94.45 (0.47) 907 93.87 (0.81) 2553 94.66 (0.57)
Past year other illicit drug useb 1149 32.66 (1.11) 351 38.40 (2.18) 798 30.57 (1.19)
Past year alcohol use disorder 1695 47.45 (1.20) 594 59.42 (1.68) 1101 43.09 (1.41)
Past year illicit drug use disorderb 347 9.70 (0.62) 144 15.30 (1.47) 203 7.66 (0.64)

SE=Standard Error

a

calculated by multiplying number of times: per day by 365; per week by 52; per month by 12; and per year by 1. For categories with ranges of response, the average of the endpoints was used. For example, 5-6 times a week was ((5*52)+(6*52))/2. There were 12 people who were missing data on frequency of cannabis use (n=3,689).

b

Illicit drug use includes sedatives/tranquilizers, opioid pain relievers, cocaine, stimulants, club drugs, hallucinogens, inhalants, heroin, and other drug

Association between Sex and Frequency of Cannabis Use and CUD

The average frequency of past-year cannabis use was higher among men than women (mean ratio=1.16, 95% CI=1.05, 1.28) (Table 2a). On average, men used cannabis on 135.3 days (SE=4.04), whereas women used cannabis on 116.4 days (SE=5.08).

Table 2a:

Association of frequency of cannabis use with sex, among past year cannabis users, NESARC-III (N=3,689)

Average number of days used (SE) Mean Ratio (95% CI) a
Men 135.3 (4.04) 1.16 (1.05, 1.28)
Women 116.4 (5.08) reference

Note:. CI = confidence interval

a

adjusted for age, race, education

The prevalence of CUD was significantly higher among men than women (28.5% v 23.8%, respectively; PD=4.7%, 95% CI: 1.29%, 8.12%) after adjusting for age, race, and education (Table 2b, Model 1). After adjusting for past-year cannabis use frequency, the sex difference narrowed (27.3% v 25.4%, respectively), and was no longer significant (PD=1.9%, 95% CI: −1.35%, 5.10%; [Table 2b, Model 2]).

Table 2b:

Association of CUD with sex, among past year cannabis users, NESARC-III (N=3,701)

Model 1a Model 2b
% CUD (SE) PD (%) (95% CI) % CUD (SE) PD (%) (95% CI)
Men 28.5 (1.24) 4.7 (1.29, 8.12) 27.3 (1.16) 1.87 (−1.35, 5.10)
Women 23.8 (1.34) reference 25.4 (1.37) reference

CUD = cannabis use disorder; PD=Prevalence Difference, percent prevalence of outcome (CUD) among men minus percent prevalence of outcome among women; CI = confidence interval.

a

adjusted for age, race, education

b

adjusted for age, race, education, past year frequency of cannabis use

Association of Sex with Psychosocial Problems

Compared to men, women had a significantly higher prevalence of problems after adjusting for age, race/ethnicity and education (Table 3, Model 1). Men were the reference category so positive numbers indicate higher prevalence among women. Women showed significantly higher prevalence of all interpersonal problems (range of PDs=4.9% to 6.6%), and some financial problems including unrepayable debt, and bankruptcy (range of PDs=1.4% to 8.2%). Additionally, women had higher prevalence of hospitalization, emergency treatment, and sleep problems (range of PDs=3.1% to 9.5%). These relationships were similar after additionally adjusting for past-year cannabis use frequency (Table 3, Model 2).

Table 3:

Association of sex with psychosocial problems, past year cannabis users, NESARC-III

Model 1a Model 2b Model 3c
Men Women Men Women Men Women
Past Year Problems % (SE) % (SE) PD (%) (95% CI) % (SE) % (SE) PD (%) (95% CI) % (SE) % (SE) PD (%) (95% CI)
Interpersonal Problems
Trouble with boss or co-workers 15.55 (0.93) 21.90 (1.21) 6.35 (3.50, 9.20) 15.45 (0.93) 21.99 (1.25) 6.54 (3.63, 9.45) 15.41 (0.93) 22.07 (1.26) 6.66 (3.73, 9.59)
Problems with neighbor, relative, or friend 13.86 (0.89) 20.48 (1.30) 6.63 (3.73, 9.52) 13.69 (0.89) 21.04 (1.35) 7.35 (4.33, 10.36) 13.64 (0.88) 21.16 (1.35) 7.53 (4.53, 10.52)
Broke up major relationship 14.57 (0.89) 19.50 (1.28) 4.93 (2.05, 7.81) 14.45 (0.90) 19.71 (1.22) 5.26 (2.47, 8.04) 14.40 (0.89) 19.81 (1.23) 5.42 (2.61, 8.23)
Financial and Legal Problems
Fired or laid off 15.28 (1.02) 15.78 (1.21) 0.50 (−2.63, 3.63) 15.09 (1.03) 15.84 (1.25) 0.76 (−2.46, 3.98) 15.08 (1.03) 15.85 (1.25) 0.77 (−2.45, 3.99)
Unemployed 31.59 (1.24) 31.47 (1.48) −0.12 (−4.03, 3.79) 31.26 (1.24) 31.87 (1.48) 0.60 (−3.35, 4.56) 31.22 (1.25) 31.94 (1.48) 0.72 (−3.25, 4.70)
Homeless 5.07 (0.52) 5.18 (0.79) 0.11 (−1.66, 1.88) 4.97 (0.50) 5.40 (0.82) 0.44 (−1.36, 2.23) 4.96 (0.50) 5.43 (0.82) 0.47 (−1.32, 2.26)
Declared bankruptcy 0.56 (0.16) 1.95 (0.41) 1.40 (0.54, 2.25) 0.55 (0.15) 2.04 (0.43) 1.49 (0.61, 2.38) 0.54 (0.15) 2.05 (0.44) 1.51 (0.62, 2.40)
So much debt couldn’t repay 22.28 (1.11) 30.45 (1.85) 8.17 (4.09, 12.24) 22.00 (1.12) 30.71 (1.85) 8.71 (4.56, 12.86) 21.96 (1.12) 30.78 (1.85) 8.82 (4.69, 12.95)
Trouble with law/police 6.93 (0.66) 5.26 (0.73) −1.66 (−3.38, 0.05) 6.76 (0.65) 5.54 (0.78) −1.22 (−3.01, 0.56) 6.74 (0.64) 5.57 (0.78) −1.17 (−2.94, 0.60)
Health-related Problems
Hospitalized 8.30 (0.71) 11.36 (0.81) 3.06 (1.09, 5.03) 8.26 (0.71) 11.37 (0.81) 3.11 (1.16, 5.07) 8.26 (0.71) 11.38 (0.81) 3.13 (1.17, 5.08)
Emergency treatment 25.74 (1.29) 33.46 (1.40) 7.72 (4.26, 11.18) 25.60 (1.30) 33.70 (1.41) 8.11 (4.60, 11.61) 25.56 (1.31) 33.78 (1.42) 8.23 (4.66, 11.79)
Suicide attempt at current age 3.09 (0.48) 4.27 (0.66) 1.18 (−0.65, 3.02) 3.10 (0.50) 4.22 (0.65) 1.12 (−0.73, 2.97) 3.10 (0.49) 4.25 (0.66) 1.15 (−0.72, 3.02)
Serious injury 26.67 (1.22) 26.28 (1.56) −0.39 (−4.35, 3.58) 26.56 (1.21) 26.48 (1.56) −0.08 (−4.03, 3.87) 26.52 (1.21) 26.55 (1.58) 0.02 (−3.96, 4.00)
Sleep problems 28.87 (1.42) 38.40 (1.70) 9.53 (5.23, 13.83) 28.64 (1.42) 38.32 (1.71) 9.68 (5.38, 13.98) 28.57 (1.41) 38.45 (1.71) 9.88 (5.60, 14.16)

CI = confidence interval; PD = prevalence difference, prevalence of outcome (consequence) among men minus prevalence of outcome among women.

a

adjusted for age, race/ethnicity, and education level

b

adjusted for age, race/ethnicity, education level, and frequency of cannabis use in the past year

c

adjusted for age, race/ethnicity, education level, frequency of cannabis use in the past year, and past year cannabis use disorder

Note: Participants with missing responses for an outcome were excluded for that analysis (range of missingness: 0 [0.0%] – 24 [0.63%]) in Models 1 and 2. Participants missing for frequency of cannabis use (12, 0.35%) were excluded from model 2. Bolded values are significant (p<.05).

Association of CUD with psychosocial problems

CUD was associated with a higher prevalence of all interpersonal problems (range of PDs=5.8%-11.4%), financial and legal problems (unemployment, homelessness, unrepayable debt, and trouble with the police/law; range of PDs=4.2% to 9.2%), and health-related problems (emergency treatment, serious injury and sleep problems; range of PDs=5.7%-12.5%) (Supplemental table 2, Model 1). This remained mostly consistent after additionally adjusting for past-year cannabis use frequency (Supplemental table 2, Model 2).

Association of CUD with Psychosocial Problems by Sex

The overall association between CUD, psychosocial and health-related problems was similar among men and women (Table 4a). Many of the problems associated with CUD did not differ by sex, including: a major relationship break-up; unemployment; homelessness; unrepayable debt; trouble with the police/law; emergency treatment; and sleep problems. However, CUD showed significantly greater association with women than men for trouble with a boss or coworkers (Difference in PD with men as reference=8%, 95% CI: 0.47%, 15.48%), and problems with a neighbor, relative, or friend (Difference in PD=9.6%, 95% CI: 2.32%, 16.84%). After adjusting for past-year cannabis use frequency (Table 4b), the association between CUD and trouble with boss or coworkers and problems with a neighbor, relative or friend remained significantly stronger among women, but CUD was no longer associated with homelessness among men or women, or with a major relationship break-up, trouble with the police/law, or sleep problems among women.

Table 4a:

Associationa of CUD with consequences, by sex, among past year cannabis users, NESARC-III

Men Women Difference between men and women
CUD = Yes CUD = No CUD = Yes CUD = No
Past Year Problems % (SE) % (SE) PD (%) (95% CI) % (SE) % (SE) PD (%) (95% CI) Difference in PD (%) (95% CI)
Interpersonal Problems
Trouble with boss or co-workers 17.60 (1.97) 14.69 (1.00) 2.92 (−1.37, 7.21) 30.13 (3.01) 19.24 (1.34) 10.89 (4.24, 17.55) 7.97 (0.47, 15.48)
Problems with neighbor, relative, or friend 19.51 (1.77) 11.61 (1.00) 7.91 (3.99, 11.83) 33.81 (3.07) 16.33 (1.35) 17.49 (10.96, 24.01) 9.58 (2.32, 16.84)
Broke up major relationship 21.53 (2.03) 11.60 (1.04) 9.93 (5.21, 14.66) 24.71 (2.82) 17.80 (1.24) 6.92 (1.36, 12.48) −3.02 (−9.80, 3.76)
Financial and Legal Problems
Fired or laid off 15.58 (1.86) 15.15 (1.17) 0.43 (−3.77, 4.63) 19.76 (2.57) 14.45 (1.42) 5.31 (−0.60, 11.21) 4.88 (−2.14, 11.89)
Unemployed 37.34 (2.20) 29.15 (1.41) 8.19 (3.34, 13.03) 39.78 (2.90) 28.71 (1.63) 11.07 (4.80, 17.34) 2.88 (−5.00, 10.77)
Homeless 7.47 (1.28) 4.07 (0.58) 3.40 (0.48, 6.32) 9.45 (2.48) 3.72 (0.65) 5.73 (0.64, 10.82) 2.32 (−3.16, 7.81)
Declared bankruptcy 1.11 (0.44) 0.35 (0.13) 0.75 (−0.13, 1.64) 2.98 (1.03) 1.66 (0.43) 1.33 (−0.85, 3.50) 0.58 (−1.43, 2.58)
So much debt couldn’t repay 26.76 (2.03) 20.57 (1.33) 6.19 (1.36, 11.03) 39.26 (3.32) 27.74 (1.89) 11.51 (5.04, 17.99) 5.32 (−2.57, 13.21)
Trouble with law/police 10.74 (1.43) 5.12 (0.69) 5.62 (2.50, 8.74) 8.69 (1.61) 3.96 (0.70) 4.73 (1.54, 7.92) −0.89 (−5.47, 3.68)
Health-related Problems
Hospitalized 9.72 (1.51) 7.76 (0.72) 1.96 (−1.13, 5.06) 11.98 (1.88) 11.18 (0.99) 0.80 (−3.63, 5.23) −1.16 (−6.68, 4.36)
Emergency treatment 30.02 (2.11) 24.00 (1.45) 6.02 (1.44, 10.59) 40.27 (3.16) 31.33 (1.67) 8.93 (1.54, 16.33) 2.92 (−6.15, 11.98)
Suicide attempt at current age 3.15 (1.22) 3.06 (0.62) 0.09 (−2.91, 3.09) 4.98 (1.75) 4.02 (0.79) 0.96 (−3.21, 5.13) 0.87 (−4.19, 5.92)
Serious injury 32.52 (2.46) 24.36 (1.24) 8.16 (3.14, 13.17) 27.23 (2.95) 26.00 (1.72) 1.23 (−5.11, 7.56) −6.93 (−15.11, 1.26)
Sleep problems 39.89 (2.17) 24.68 (1.64) 15.21 (10.07, 20.34) 44.15 (2.81) 36.67 (1.99) 7.48 (0.94, 14.02) −7.73 (−16.76, 1.30)

CUD = cannabis use disorder; CI = confidence interval; PD = prevalence difference, prevalence of outcome (consequence) among those with CUD minus prevalence of outcome among those without CUD.

a

adjusted for age, race/ethnicity, education level

Note: Participants with missing responses for an outcome were excluded for that analysis (range of missingness: 0 [0.0%] – 24 [0.63%]).

Table 4b:

Associationa of CUD with consequences, by sex, among past year cannabis users, adjusted for frequency of cannabis use, NESARC-III

Men Women
CUD = Yes CUD = No CUD = Yes CUD = No Difference between men and women
Past Year Problems % (SE) % (SE) PD (%) (95% CI) % (SE) % (SE) PD (%) (95% CI) Difference in PD (%) (95% CI)
Interpersonal Problems
Trouble with boss or co-workers 17.87 (2.00) 14.55 (0.97) 3.32 (−0.89, 7.53) 30.55 (3.04) 19.08 (1.39) 11.46 (4.64, 18.28) 8.15 (0.63, 15.66)
Problems with neighbor, relative, or friend 18.32 (1.73) 11.85 (1.02) 6.47 (2.60, 10.35) 32.44 (3.04) 16.98 (1.48) 15.46 (8.68, 22.23) 8.98 (1.77, 16.20)
Broke up major relationship 21.04 (2.28) 11.70 (1.08) 9.34 (3.97, 14.70) 23.77 (3.06) 18.12 (1.22) 5.65 (−0.79, 12.10) −3.69 (−10.52, 3.15)
Financial and Legal Problems
Fired or laid off 14.42 (1.92) 15.40 (1.20) −0.98 (−5.40, 3.43) 18.39 (2.59) 14.92 (1.51) 3.47 (−2.62, 9.57) 4.46 (−2.32, 11.23)
Unemployed 35.15 (2.23) 29.66 (1.41) 5.49 (0.58, 10.40) 37.68 (3.07) 29.71 (1.70) 7.97 (1.06, 14.88) 2.48 (−5.47, 10.43)
Homeless 6.37 (1.21) 4.29 (0.63) 2.08 (−0.85, 5.01) 8.17 (2.19) 4.15 (0.73) 4.02 (−0.60, 8.64) 1.94 (−2.95, 6.84)
Declared bankruptcy 0.97 (0.39) 0.37 (0.14) 0.61 (−0.20, 1.41) 2.67 (0.94) 1.79 (0.47) 0.88 (−1.16, 2.93) 0.28 (−1.60, 2.16)
So much debt couldn’t repay 26.06 (2.17) 20.54 (1.29) 5.52 (0.65, 10.40) 38.82 (3.34) 27.99 (1.90) 10.83 (4.22, 17.44) 5.31 (−2.58, 13.20)
Trouble with law/police 9.01 (1.22) 5.48 (0.75) 3.53 (0.72, 6.34) 7.41 (1.36) 4.54 (0.84) 2.87 (−0.07, 5.82) −0.65 (−4.66, 3.35)
Health-related Problems
Hospitalized 9.19 (1.48) 7.89 (0.73) 1.31 (−1.77, 4.39) 11.40 (1.83) 11.34 (1.00) 0.06 (−4.29, 4.41) −1.25 (−6.57, 4.08)
Emergency treatment 29.54 (2.15) 24.08 (1.47) 5.46 (0.76, 10.16) 40.06 (3.27) 31.51 (1.70) 8.54 (0.89, 16.19) 3.08 (−5.92, 12.09)
Suicide attempt, current age 3.33 (1.38) 3.05 (0.61) 0.28 (−3.00, 3.55) 6.14 (2.27) 3.82 (0.68) 2.31 (−2.59, 7.22) 2.04 (−3.73, 7.80)
Serious injury 32.51 (2.53) 24.31 (1.27) 8.20 (2.83, 13.56) 27.49 (3.02) 26.04 (1.69) 1.45 (−4.93, 7.84) −6.74 (−15.00, 1.51)
Sleep problems 39.91 (2.35) 24.58 (1.61) 15.33 (9.98, 20.69) 43.79 (3.09) 36.36 (2.07) 7.43 (−0.03, 14.90) −7.90 (−17.16, 1.36)

CUD = cannabis use disorder; CI = confidence interval

a

adjusted for age, race/ethnicity, education level, frequency of past year cannabis use

b

PD = prevalence difference, prevalence of outcome (consequence) among those with CUD minus prevalence of outcome among those without CUD

Note: Participants with missing responses for an outcome were excluded for that analysis (range of missingness: 0 [0.0%] – 24 [0.63%]). Participants missing for frequency of cannabis use (12, 0.35%) were excluded as well.

Sensitivity Analyses

We conducted sensitivity analyses for the associations between sex, cannabis use frequency, CUD, and psychosocial problems, additionally adjusting for past-year alcohol and drug use or AUD and DUD. Results were generally the same as main analyses. The average frequency of cannabis use remained higher among men than women (Supplemental Table 3a), and there continued to be no significant sex difference in prevalence of CUD after adjusting for past-year cannabis use frequency (Supplemental Table 3b). Women continued to show significantly higher prevalence of interpersonal, financial, and health-related problems after adjusting for past-year alcohol and drug use (Supplemental Table 4, Model 1) or past-year AUD and DUD (Supplemental Table 4, Model 2). CUD also remained significantly associated with psychosocial and health-related problems (Supplemental Table 5). Finally, women with CUD continued to have a greater association with interpersonal problems than men, after adjusting for past-year alcohol and drug use (Supplemental Table 6a). After adjusting for past-year AUD and DUD (Supplemental Table 6b) the association between CUD and trouble with boss or coworkers was no longer significantly higher among women.

DISCUSSION

Using nationally representative data of US adults who used cannabis in the past year, our study found that men had a greater prevalence of CUD than women, but this difference was partly explained by sex differences in frequency of cannabis use. The prevalence of psychosocial and health-related problems was elevated among both men and women with CUD, but women had a greater likelihood of reporting trouble with boss or co-workers, and problems with a neighbor, relative or friend. These findings suggest that men and women with similar cannabis use frequencies have a similar likelihood of CUD, but women were significantly more likely to report interpersonal problems associated with CUD.

Similar to previous literature, the majority of people who used cannabis in the past year, and people with CUD in the past year, were men.3,8,18,19,32 However, sex differences were no longer significant after adjusting for frequency of use, suggesting the gender gap in CUD and the higher likelihood of transition from cannabis use to CUD among men20,21 may be due to higher frequency of cannabis use among men.7 Evidence that women progress from cannabis initiation to CUD more quickly than men (i.e., telescoping)7,8,33 may also be due to rapid escalation in frequency of use, especially as women are more likely to experience cannabis withdrawal symptoms.34,35 These results are consistent with a previous study showing that the association between cannabis use frequency and CUD did not vary by sex.32 Because our results indicate cannabis use frequency may help explain sex differences in the prevalence of CUD, frequency of cannabis use may be an important target for CUD prevention efforts among men and women who use cannabis. High-frequency cannabis use is associated with a greater risk of developing CUD,1 therefore CUD prevention efforts may include online or in-person treatment interventions such as motivational interviewing, cognitive behavioral therapy, or personalized normative feedback assessing baseline cannabis use and aim to reduce past-month cannabis use frequency.36,37 Such programs have contributed to reductions in past-month cannabis use frequency among cannabis users.36,37

The increased likelihood of interpersonal problems among women with CUD is consistent with previous literature showing women with CUD were more likely to be unemployed, have mood or anxiety disorders, and mental health decrements.7,22 The elevated prevalence of problems with a boss or co-worker among women with CUD may contribute to unemployment. Furthermore, increased interpersonal problems among women with CUD may associated with CUD-related mood and anxiety disorders.30,3842 Women are also more likely to experience cannabis withdrawal symptoms,34,35 which overlap with depression and anxiety symptoms4345 and may contribute to self-medication with cannabis and increased use to maintain symptom relief.46,47 Sex differences in mood and anxiety disorders and cannabis withdrawal may provide context for the higher likelihood of interpersonal problems among women with CUD. These results were also robust to additional sensitivity analyses adjusting for past-year alcohol and drug use, but differential associations between women and men were attenuated after adjusting for AUD and DUD. Efforts to prevent CUD among women should include screening for cannabis withdrawal symptoms that may promote more frequent cannabis use for self-medication and increase the risk for developing CUD, health education efforts regarding risks associated with increased frequency of cannabis use, and helping clients or patients learn more effective stress-coping strategies.46,48 These results also suggest the need for sex-specific treatment for women with CUD,49 with an emphasis on strengthening social support networks to reduce the risk of interpersonal problems.

A previous study showed no sex differences in cannabis-related problems after adjusting for frequency and quantity of past-year cannabis use.32 The lack of sex differences may be because the previous study defined cannabis-related problems using subscales of CUD DSM-5 criteria, rather than independent psychosocial or health-related problems. We found no sex differences in likelihood of CUD after adjusting for frequency of use, so we would expect cannabis-related problems defined using DSM-5 criteria would also not differ.

Study limitations are noted. First, the cross-sectional design of the NESARC-III does not allow us to infer the direction of the association between CUD and psychosocial and health-related problems. Although individuals may use cannabis as self-medication to cope with psychosocial or health-related problems,46 our findings are consistent with longitudinal studies examining the adverse consequences of cannabis exposure.50 Future studies should leverage longitudinal data to understand the direction of association. Second, certain DSM-5 CUD criteria (e.g., social problems or neglecting professional responsibilities)43 may be highly correlated with interpersonal and financial problems evaluated. However, our analysis extended the literature by evaluating sex differences in problems associated with CUD. Future studies may consider evaluating associational differences accounting for which DSM-5 criteria were met. Third, CUD may be underreported due to social desirability or recall bias, particularly in the context of the 2012-2013 cannabis legal landscape when states first began to legalize recreational cannabis use.51 Women may also be more likely to under-report CUD, particularly when pregnant, due to fear of legal repercussions of substance use.52 If there was differential misclassification of exposure among women, whereby women with CUD were misclassified as unexposed, then the reported relationship between CUD and psychosocial problems among women may be underestimated. Fourth, similar to other nationally representative surveys, the NESARC-III excludes people who are institutionalized (e.g., incarcerated) or homeless. Substance use disorders are associated with increased risk of institutionalization and homelessness and there are potential sex differences in this relationship,5358 suggesting our estimates of the association between CUD, homelessness, and trouble with the police/law, and sex differences in these associations may be conservative.

CONCLUSION

Our study of past-year cannabis users found that sex differences in the likelihood of CUD may be explained by frequency of use, but women showed greater prevalence of interpersonal, financial, and health-related problems. As changes in cannabis legalization policies have been associated with both increased frequent cannabis use and CUD among US adults,59 our findings may suggest that frequency of use is an important target for CUD prevention strategies. Although CUD was associated with interpersonal, financial, legal, and health-related problems among both men and women, women with CUD had greater prevalence of reporting interpersonal problems than men. Differences in interpersonal problems may be due to the worse mental health outcomes among women with CUD, suggesting that CUD treatment for women should focus on increasing support among interpersonal relationships.

Supplementary Material

1

FUNDING

This work was supported by NIDA grants: R01DA048860 (PI: Hasin),T32DA031099 (PI: Hasin), and New York State Psychiatric Institute.

REFERENCES

  • 1.Leung J, Chan GC, Hides L, Hall WD. What is the prevalence and risk of cannabis use disorders among people who use cannabis? A systematic review and meta-analysis. Addictive Behaviors. 2020;109:106479. [DOI] [PubMed] [Google Scholar]
  • 2.Substance Abuse and Mental Health Services Administration. Key Substance Use and Mental Health Indicators in the United States: Results from the 2019 National Survey on Drug Use and Health. Rockville, MD: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration;2020. [Google Scholar]
  • 3.Hasin DS. US epidemiology of cannabis use and associated problems. Neuropsychopharmacology. 2018;43(1):195–212. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Compton WM, Han B, Jones CM, Blanco C. Cannabis use disorders among adults in the United States during a time of increasing use of cannabis. Drug and alcohol dependence. 2019;204:107468. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Hasin DS, Saha TD, Kerridge BT, et al. Prevalence of marijuana use disorders in the United States between 2001-2002 and 2012-2013. JAMA psychiatry. 2015;72(12):1235–1242. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Azofeifa A, Mattson ME, Schauer G, McAfee T, Grant A, Lyerla R. National estimates of marijuana use and related indicators—National Survey on Drug Use and Health, United States, 2002–2014. Morbidity and Mortality Weekly Report: Surveillance Summaries. 2016;65(11):1–25. [DOI] [PubMed] [Google Scholar]
  • 7.Khan SS, Secades-Villa R, Okuda M, et al. Gender differences in cannabis use disorders: results from the National Epidemiologic Survey of Alcohol and Related Conditions. Drug and alcohol dependence. 2013;130(1–3):101–108. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Kerridge BT, Pickering R, Chou P, Saha TD, Hasin DS. DSM-5 cannabis use disorder in the National Epidemiologic Survey on Alcohol and Related Conditions-III: Gender-specific profiles. Addictive Behaviors. 2018;76:52–60. [DOI] [PubMed] [Google Scholar]
  • 9.Hasin D, Walsh C. Cannabis use, cannabis use disorder, and comorbid psychiatric illness: A narrative review. Journal of Clinical Medicine. 2020;10(1):15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Murrie B, Lappin J, Large M, Sara G. Transition of substance-induced, brief, and atypical psychoses to schizophrenia: a systematic review and meta-analysis. Schizophrenia bulletin. 2020;46(3):505–516. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Martinotti G, De Risio L, Vannini C, Schifano F, Pettorruso M, Di Giannantonio M. Substance-related exogenous psychosis: a postmodern syndrome. CNS spectrums. 2021;26(1):84–91. [DOI] [PubMed] [Google Scholar]
  • 12.Marconi A, Di Forti M, Lewis CM, Murray RM, Vassos E. Meta-analysis of the association between the level of cannabis use and risk of psychosis. Schizophrenia bulletin. 2016;42(5):1262–1269. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Gryczynski J, Schwartz RP, O’Grady KE, Restivo L, Mitchell SG, Jaffe JH. Understanding patterns of high-cost health care use across different substance user groups. Health Affairs. 2016;35(1):12–19. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Gutkind S, Fink DS, Shmulewitz D, Stohl M, Hasin D. Psychosocial and health problems associated with alcohol use disorder and cannabis use disorder in US adults. Drug and alcohol dependence. 2021;229:109137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Hasin DS, Kerridge BT, Saha TD, et al. Prevalence and correlates of DSM-5 cannabis use disorder, 2012-2013: findings from the National Epidemiologic Survey on Alcohol and Related Conditions–III. American Journal of Psychiatry. 2016;173(6):588–599. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Carliner H, Mauro PM, Brown QL, et al. The widening gender gap in marijuana use prevalence in the US during a period of economic change, 2002–2014. Drug and alcohol dependence. 2017;170:51–58. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Hasin DS, Shmulewitz D, Sarvet AL. Time trends in US cannabis use and cannabis use disorders overall and by sociodemographic subgroups: a narrative review and new findings. The American journal of drug and alcohol abuse. 2019;45(6):623–643. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Chapman C, Slade T, Swift W, Keyes K, Tonks Z, Teesson M. Evidence for sex convergence in prevalence of cannabis use: a systematic review and meta-regression. Journal of studies on alcohol and drugs. 2017;78(3):344–352. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Kozak K, H. Smith P, Lowe DJ, et al. A systematic review and meta-analysis of sex differences in cannabis use disorder amongst people with comorbid mental illness. The American journal of drug and alcohol abuse. 2021;47(5):535–547. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Feingold D, Livne O, Rehm J, Lev-Ran S. Probability and correlates of transition from cannabis use to DSM-5 cannabis use disorder: Results from a large-scale nationally representative study. Drug and alcohol review. 2020;39(2):142–151. [DOI] [PubMed] [Google Scholar]
  • 21.Lopez-Quintero C, de los Cobos JP, Hasin DS, et al. Probability and predictors of transition from first use to dependence on nicotine, alcohol, cannabis, and cocaine: Results of the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). Drug and alcohol dependence. 2011;115(1–2):120–130. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Lev-Ran S, Imtiaz S, Taylor BJ, Shield KD, Rehm J, Le Foll B. Gender differences in health-related quality of life among cannabis users: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Drug and alcohol dependence. 2012;123(1–3):190–200. [DOI] [PubMed] [Google Scholar]
  • 23.Fischer B, Jeffries V, Hall W, Room R, Goldner E, Rehm J. Lower Risk Cannabis Use Guidelines for Canada (LRCUG): a narrative review of evidence and recommendations. Canadian journal of public health. 2011;102(5):324–327. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Grant BF, Goldstein RB, Saha TD, et al. Epidemiology of DSM-5 alcohol use disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions III. JAMA psychiatry. 2015;72(8):757–766. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Grant B, Chu A, Sigman R, et al. Source and accuracy statement. Evaluation. 2003;2:6. [Google Scholar]
  • 26.Grant BF, Goldstein RB, Smith SM, et al. The Alcohol Use Disorder and Associated Disabilities Interview Schedule-5 (AUDADIS-5): reliability of substance use and psychiatric disorder modules in a general population sample. Drug and alcohol dependence. 2015;148:27–33. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Hasin DS, Greenstein E, Aivadyan C, et al. The Alcohol Use Disorder and Associated Disabilities Interview Schedule-5 (AUDADIS-5): procedural validity of substance use disorders modules through clinical re-appraisal in a general population sample. Drug and alcohol dependence. 2015;148:40–46. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Hasin D, Shmulewitz D, Stohl M, et al. Test-retest reliability of DSM-5 substance disorder measures as assessed with the PRISM-5, a clinician-administered diagnostic interview. Drug and alcohol dependence. 2020;216:108294. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Mood C Logistic regression: Why we cannot do what we think we can do, and what we can do about it. European sociological review. 2010;26(1):67–82. [Google Scholar]
  • 30.Pacek LR, Martins SS, Crum RM. The bidirectional relationships between alcohol, cannabis, co-occurring alcohol and cannabis use disorders with major depressive disorder: results from a national sample. Journal of affective disorders. 2013;148(2–3):188–195. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.De Aquino JP, Sofuoglu M, Stefanovics E, Rosenheck R. Adverse consequences of co-occurring opioid use disorder and Cannabis use disorder compared to opioid use disorder only. The American Journal of Drug and Alcohol Abuse. 2019;45(5):527–537. [DOI] [PubMed] [Google Scholar]
  • 32.Callaghan RC, Sanches M, Kish SJ. Quantity and frequency of cannabis use in relation to cannabis-use disorder and cannabis-related problems. Drug and Alcohol Dependence. 2020;217:108271. [DOI] [PubMed] [Google Scholar]
  • 33.Lewis B, Hoffman LA, Nixon SJ. Sex differences in drug use among polysubstance users. Drug and alcohol dependence. 2014;145:127–133. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Herrmann ES, Weerts EM, Vandrey R. Sex differences in cannabis withdrawal symptoms among treatment-seeking cannabis users. Experimental and clinical psychopharmacology. 2015;23(6):415. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Copersino ML, Boyd SJ, Tashkin DP, et al. Sociodemographic characteristics of cannabis smokers and the experience of cannabis withdrawal. The American journal of drug and alcohol abuse. 2010;36(6):311–319. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Halladay J, Scherer J, MacKillop J, et al. Brief interventions for cannabis use in emerging adults: A systematic review, meta-analysis, and evidence map. Drug and alcohol dependence. 2019;204:107565. [DOI] [PubMed] [Google Scholar]
  • 37.Boumparis N, Loheide-Niesmann L, Blankers M, et al. Short-and long-term effects of digital prevention and treatment interventions for cannabis use reduction: A systematic review and meta-analysis. Drug and alcohol dependence. 2019;200:82–94. [DOI] [PubMed] [Google Scholar]
  • 38.Whisman MA, Sheldon CT, Goering P. Psychiatric disorders and dissatisfaction with social relationships: Does type of relationship matter? Journal of abnormal psychology. 2000;109(4):803. [DOI] [PubMed] [Google Scholar]
  • 39.Euler S, Nolte T, Constantinou M, et al. Interpersonal problems in borderline personality disorder: associations with mentalizing, emotion regulation, and impulsiveness. Journal of Personality Disorders. 2021;35(2):177–193. [DOI] [PubMed] [Google Scholar]
  • 40.Tonge NA, Lim MH, Piccirillo ML, Fernandez KC, Langer JK, Rodebaugh TL. Interpersonal problems in social anxiety disorder across different relational contexts. Journal of anxiety disorders. 2020;75:102275. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Triscoli C, Croy I, Sailer U. Depression predicts interpersonal problems partially through the attitude towards social touch. Journal of affective disorders. 2019;246:234–240. [DOI] [PubMed] [Google Scholar]
  • 42.Barrett MS, Barber JP. Interpersonal profiles in major depressive disorder. Journal of clinical psychology. 2007;63(3):247–266. [DOI] [PubMed] [Google Scholar]
  • 43.American Psychiatric Association D, Association AP. Diagnostic and statistical manual of mental disorders: DSM-5. Vol 5: American psychiatric association; Washington, DC; 2013. [Google Scholar]
  • 44.Budney AJ, Hughes JR, Moore BA, Vandrey R. Review of the validity and significance of cannabis withdrawal syndrome. American journal of Psychiatry. 2004;161(11):1967–1977. [DOI] [PubMed] [Google Scholar]
  • 45.Levin KH, Copersino ML, Heishman SJ, et al. Cannabis withdrawal symptoms in non-treatment-seeking adult cannabis smokers. Drug and alcohol dependence. 2010;111(1–2):120–127. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Sarvet AL, Wall MM, Keyes KM, Olfson M, Cerdá M, Hasin DS. Self-medication of mood and anxiety disorders with marijuana: higher in states with medical marijuana laws. Drug and alcohol dependence. 2018;186:10–15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Gorfinkel LR, Stohl M, Hasin D. Association of depression with past-month cannabis use among US adults aged 20 to 59 years, 2005 to 2016. JAMA network open. 2020;3(8):e2013802–e2013802. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Hyman SM, Sinha R. Stress-related factors in cannabis use and misuse: implications for prevention and treatment. Journal of substance abuse treatment. 2009;36(4):400–413. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Brabete AC, Greaves L, Hemsing N, Stinson J. Sex-and gender-based analysis in cannabis treatment outcomes: a systematic review. International Journal of Environmental Research and Public Health. 2020;17(3):872. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Hall W, Degenhardt L. Adverse health effects of non-medical cannabis use. The Lancet. 2009;374(9698):1383–1391. [DOI] [PubMed] [Google Scholar]
  • 51.ProCon.org. Recreational Marijuana Legality by State. https://marijuana.procon.org/legal-recreational-marijuana-states-and-dc/. Published 2022. Accessed May 1, 2022.
  • 52.Woodruff K, Scott KA, Roberts SC. Pregnant people’s experiences discussing their cannabis use with prenatal care providers in a state with legalized cannabis. Drug and Alcohol Dependence. 2021;227:108998. [DOI] [PubMed] [Google Scholar]
  • 53.Thompson RG Jr, Wall MM, Greenstein E, Grant BF, Hasin DS. Substance-use disorders and poverty as prospective predictors of first-time homelessness in the United States. American journal of public health. 2013;103(S2):S282–S288. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Caton CL, Dominguez B, Schanzer B, et al. Risk factors for long-term homelessness: Findings from a longitudinal study of first-time homeless single adults. American journal of public health. 2005;95(10):1753–1759. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Fazel S, Geddes JR, Kushel M. The health of homeless people in high-income countries: descriptive epidemiology, health consequences, and clinical and policy recommendations. The Lancet. 2014;384(9953):1529–1540. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Montgomery AE, Szymkowiak D, Culhane D. Gender differences in factors associated with unsheltered status and increased risk of premature mortality among individuals experiencing homelessness. Women’s health issues. 2017;27(3):256–263. [DOI] [PubMed] [Google Scholar]
  • 57.Peters RH, Greenbaum PE, Edens JF, Carter CR, Ortiz MM. Prevalence of DSM-IV substance abuse and dependence disorders among prison inmates. The American journal of drug and alcohol abuse. 1998;24(4):573–587. [DOI] [PubMed] [Google Scholar]
  • 58.Baranyi G, Fazel S, Langerfeldt SD, Mundt AP. The prevalence of comorbid serious mental illnesses and substance use disorders in prison populations: a systematic review and meta-analysis. The Lancet Public Health. 2022;7(6):e557–e568. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Cerdá M, Mauro C, Hamilton A, et al. Association between recreational marijuana legalization in the United States and changes in marijuana use and cannabis use disorder from 2008 to 2016. JAMA psychiatry. 2020;77(2):165–171. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

1

RESOURCES